Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Pharmaceutical Journal of Indonesia Hubungan Tingkat Pengetahuan Petugas Pengelola Obat dengan Tingkat Ketersediaan Obat Di Puskesmas Kota Malang
Etika, Trias
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Analisis Cost of Illness Pada Pasien Hipertensi Peserta BPJS Rawat Jalan di Puskesmas Banyuanyar Etika, Trias
Pharmaceutical Journal of Indonesia Vol 6, No 1 (2020)
Publisher : Brawijaya University

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Hypertension is a chronic disease that requires regular therapy to control blood pressure. The cost of treating hypertension can be measured using a Cost of Illness analysis. The Purpose of this study to find out the total cost of treating hypertensive patients participating in BPJS with Captopril therapy for one year for outpatient treatment at the Banyuanyar Public Health Center in Sampang Regency. Method this study used a non-random sampling technique with a purposive sampling method. This research conducted at Banyuanyar Health Center with total sample 40 people. The instrument used a structured interview which was previously tested for validity. Data were analyzed using Microsoft Excel. Result and Conclusions this study is the cost of illness for hypertensive patients for one year is Rp. 36,140 to Rp. 2,528.000. The total range of direct medical costs is Rp. 36,140 to Rp. 368.000 per patient, the range of direct non-medical costs is Rp. 0 to Rp. 360,000 per patient, and the range of indirect costs is Rp. 0 to Rp. 1,800,000 per patient. The large cost value range and small cost value are influenced by the frequency of patient visits.  Small costs are cheaper but with the frequency of patient visits and disorderly patient compliance so that the therapeutic effects achieved are less good, while large costs are more expensive but with the frequency of patient visits and orderly patient compliance so that the therapeutic effects achieved are good and maximal.
Analisis Cost of Illness Pada Pasien Hipertensi Peserta BPJS Rawat Jalan di Puskesmas Banyuanyar Etika, Trias
Pharmaceutical Journal of Indonesia Vol 6, No 1 (2020)
Publisher : Brawijaya University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.pji.2020.006.01.7

Abstract

Hypertension is a chronic disease that requires regular therapy to control blood pressure. The cost of treating hypertension can be measured using a Cost of Illness analysis. The Purpose of this study to find out the total cost of treating hypertensive patients participating in BPJS with Captopril therapy for one year for outpatient treatment at the Banyuanyar Public Health Center in Sampang Regency. Method this study used a non-random sampling technique with a purposive sampling method. This research conducted at Banyuanyar Health Center with total sample 40 people. The instrument used a structured interview which was previously tested for validity. Data were analyzed using Microsoft Excel. Result and Conclusions this study is the cost of illness for hypertensive patients for one year is Rp. 36,140 to Rp. 2,528.000. The total range of direct medical costs is Rp. 36,140 to Rp. 368.000 per patient, the range of direct non-medical costs is Rp. 0 to Rp. 360,000 per patient, and the range of indirect costs is Rp. 0 to Rp. 1,800,000 per patient. The large cost value range and small cost value are influenced by the frequency of patient visits.  Small costs are cheaper but with the frequency of patient visits and disorderly patient compliance so that the therapeutic effects achieved are less good, while large costs are more expensive but with the frequency of patient visits and orderly patient compliance so that the therapeutic effects achieved are good and maximal.
Co-Authors